首页> 外文会议>Mediterranean Conference on Medical and Biological Engineering and Computin >Telemedieine and mHealth System for Complex Management in T1DM and T2DM Patients: Results of 6 Months Study
【24h】

Telemedieine and mHealth System for Complex Management in T1DM and T2DM Patients: Results of 6 Months Study

机译:T1DM和T2DM患者复杂管理的Telemeedieine和MHEATH系统:6个月的结果

获取原文

摘要

Paper focuses on evaluation of clinical outcomes in management of diabetic patients based on proactive care. Patients were empowered toward self-management through integrated telemedicine system. We used two different patient datasets to evaluate clinical outcomes - dataset A with 95 T1DM (Type 1 diabetes mellitus) and 121 T2DM (Type 2 diabetes) patients and dataset B with 148 T1DM and 218 T2DM patients. The results show significant improvements for both datasets in HbA1c (glycosylated hemoglobin) for T1DM and T2DM patients in 6 month period. Baseline for HbA1c in Dataset A for T1DM patients: 7.55±1.68% versus 7.21±1.59% after six months using telemedieine services (p = 0.003). Baseline for HbA1c for T2DM patients: 6.98±1.55% versus 6.56±1.42% (p = 0). Baseline for HbA1c in Dataset B for T1DM patients: 7.73±1.62% versus 7.38±1.57% after six months using telemedieine services (p = 0). Baseline for HbA1c for T2DM patients: 7.1±1.54% versus 6.77±1.45% (p = 0).
机译:论文侧重于基于主动护理的糖尿病患者管理临床结果评估。患者通过集成远程医疗系统赋予自我管理。我们使用了两种不同的患者数据集来评估临床结果 - DataSet A用95 T1DM(1型糖尿病)和121吨T2DM(2型糖尿病)患者和数据集B,具有148 T1DM和218 T2DM患者。结果表明,在6个月期间,HBA1C(糖基化血红蛋白)对HBA1C(糖基化血红蛋白)的数据集显着改进,T1DM和T2DM患者。用于T1DM患者的数据集A中HBA1C的基线:使用TelemeDieine服务六个月后7.55±1.68%与7.21±1.59%(p = 0.003)。用于T2DM患者的HBA1C的基线:6.98±1.55%,与6.56±1.42%(P = 0)。用于T1DM患者的数据集B中的HBA1C基线:使用TelemeDieine服务六个月后7.73±1.62%与7.38±1.57%(P = 0)。用于T2DM患者的HBA1C的基线:7.1±1.54%,与6.77±1.45%(P = 0)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号